Homologous recombination deficiency (HRD) in 543 ovarian cancer samples: A single center hands-on experience

被引：0
|
作者：
Kotsakis, A. [1 ]
Konstantoulakis, P. [2 ]
Christopoulou, G. [2 ]
Samara, S. [2 ]
Oikonomaki, A. [2 ]
Roumelioti, K. [2 ]
Pachitsa, F. [2 ]
Koinis, F. [3 ]
Georgoulias, V. [4 ]
机构：
[1] Univ Gen Hosp Larissa, Dept Med Oncol, Larisa, Greece
[2] Genotypos Sci Labs, Genom, Athens, Greece
[3] Univ Hosp Larissa, Dept Med Oncol, Larisa, Greece
[4] Metropolitan Gen Hosp, Dept Med Oncol 1, Iraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.709
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581P
引用
收藏
页码：S813 / S813
页数：1
相关论文
共 50 条
  • [21] Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC).
    Patel, Jai Narendra
    Sehouli, Jahid
    Timms, Kirsten
    Solimeno, Cara
    Reid, Julia E.
    Lanchbury, Jerry S.
    Braicu, Ioana
    Darb-Esfahani, Silvia
    Ganapathi, Mahrukh
    Ganapathi, Ram N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Role of BRCA1 promotor methylation in homologous recombination deficiency (HRD) in high-grade ovarian cancer
    Fiegl, H.
    Reimer, D.
    Schnaiter, S.
    Leitner, K.
    Wimmer, K.
    Schamschula, E.
    Steger, K.
    Marth, C.
    Zeimet, A. G.
    ANNALS OF ONCOLOGY, 2023, 34 : S527 - S527
  • [23] An optimized homologous recombination deficiency (HRD) algorithm ASGAD for predicting PARP inhibitor response in ovarian cancer patient.
    Jiao, Yang
    Chen, Dong Ju
    Liu, Bo
    Meng, Pei
    Sun, Lei
    Cai, Yu Hang
    Shi, Tai Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] In-House Testing for Homologous Recombination Deficiency (HRD) in Mexican Patients with High-Grade Serous Ovarian Cancer
    Abreu-Gonzalez, Melania
    Santillan-Martinez, Rosalia
    Garcia-Ortiz, Ramiro
    Alvarez Ordorica, Oliver
    Martinez-Cannon, Bertha A.
    Hernandez Luis, Gisela
    Tellez Bernal, Eduardo
    Cortes Esteban, Patricia
    Blanco Vazquez, Yazmin C.
    Lopez Rosas, Gilberto
    Gomez Garcia, Eva M.
    Sanchez Llamas, Benito
    Rojas Toledo, Emma X.
    Martinez Gutierrez, Selena
    Azotla Vilchis, Coztli O.
    Rodriguez Munoz, Yolanda F.
    Munoz, Alexia
    Montes-Servin, Edgar
    Mendoza-Maldonado, Lucero
    Vaisman, Carolina E.
    Juarez Rodriguez, Rocio
    Flores Palacios, Jose A.
    Lara Torres, Cesar O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S53 - S54
  • [25] Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC)
    Patel, J.
    Sehouli, J.
    Timms, K.
    Solimeno, C.
    Reid, J.
    Lanchbury, J.
    Braicu, I.
    Darb-Esfahani, S.
    Ganapathi, M.
    Ganapathi, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Development of model for identifying homologous recombination deficiency (HRD) status of ovarian cancer with deep learning on whole slide images
    Zhang, Ke
    Qiu, Youhui
    Feng, Songwei
    Yin, Han
    Liu, Qi
    Zhu, Yuxin
    Cui, Haoyu
    Wei, Xiaoying
    Wang, Guoqing
    Wang, Xiangxue
    Shen, Yang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [27] Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer
    Fountzilas, Elena
    Papadopoulou, Kyriaki
    Chatzikonstantinou, Thomas
    Karakatsoulis, Georgios
    Constantoulakis, Pantelis
    Tsantikidi, Aikaterini
    Tsaousis, Georgios
    Karageorgopoulou, Sofia
    Koumarianou, Anna
    Mauri, Davide
    Ntavatzikos, Anastasios
    Saridaki, Zacharenia
    Petrakis, Georgios
    Fostira, Florentia
    Fountzilas, George
    Liontos, Michalis
    CANCERS, 2023, 15 (23)
  • [28] Breast cancer whole genomes link homologous recombination deficiency (HRD) with therapeutic outcomes
    Zhao, Eric Y.
    Shen, Yaoqing
    Pleasance, Erin
    Kasaian, Katayoon
    Jones, Martin R.
    Ch'ng, Carolyn
    Reisle, Caralyn
    Eirew, Peter
    Mungall, Karen
    Thiessen, Nina
    Ma, Yussanne
    Fok, Alexandra
    Mungall, Andrew J.
    Zhao, Yongjun
    Moore, Richard
    Villa, Diego
    Shenkier, Tamara
    Lohrisch, Caroline
    Chia, Stephen
    Yip, Stephen
    Gelmon, Karen
    Lim, Howard
    Sun, Sophie
    Schrader, Kasmintan A.
    Young, Sean
    Karsan, Aly
    Roscoe, Robyn
    Laskin, Janessa
    Marra, Marco A.
    Jones, Steven J.
    CANCER RESEARCH, 2017, 77
  • [29] Characterization of mutational signatures of homologous recombination deficiency (HRD) in Chinese breast cancer.
    Liu, Xiao
    Li, Mingwei
    Lou, Feng
    Cao, Shanbo
    Wang, Huina
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Homologous recombination deficiency testing in Vietnamese patients with ovarian cancer
    Tran, N. H.
    Nguyen, P.
    Nguyen, T. A.
    Tu, L.
    ANNALS OF ONCOLOGY, 2024, 35
12345